Details of the Drug
General Information of Drug (ID: DMBHUKV)
Drug Name |
Methyl L-phenylalaninate
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
Methyl 2-amino-3-phenylpropanoate; 15028-44-1; Methyl 3-phenyl-DL-alaninate; H-DL-Phe-OMe HCl; DL-phenylalanine methyl ester; VSDUZFOSJDMAFZ-UHFFFAOYSA-N; 2-Amino-3-phenyl-propionic acid methyl ester; phenylalanine, methyl ester; F2147-0643; l-phe methyl ester; EINECS 239-109-5; AC1L2PEY; Phenylalanine, methylester; AC1Q41SQ; AC1Q41SP; AC1Q41RL; SCHEMBL74887; D,L-phenylalanine methyl ester; DL-Phenylalanine, methyl ester; Methyl L-phenylalaninate (HCl); CTK4C6579; STK019373; MFCD00044582; NSC522409; BBL009783; AKOS016042462
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 179.22 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | 1.1 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 4 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 1 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 3 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||